You are here
iCMLf Forum 2017: Perspectives on Treatment Free Remission: Perspectives from Brazil
Topics include; outpatients public health system - Brazil procedure, discontinuation trials in Brazil including USP trial: imatinib discontinuation in patients with CML-CP with sustainded MR4log and EDI-PIO: pilot study of imatinb discontinuation in patients with CML with deep molecular response, barriers for TKI discontinuation in Brazil outside clinical trials.